More about

Venous Thromboembolism

News
December 11, 2022
4 min watch
Save

Biomarkers predict thromboembolism risk, mortality among people with cancer, COVID-19

NEW ORLEANS — Patients with cancer and COVID-19 exhibited a 3% risk for thromboembolism within 30 days of their first positive test, according to study results presented at ASH Annual Meeting and Exposition.

News
December 07, 2022
3 min read
Save

Opioids nearly double risk for venous thromboembolism vs. NSAIDs in rheumatoid arthritis

PHILADELPHIA — Opioid use in rheumatoid arthritis demonstrates a nearly two-fold increased risk for venous thromboembolism vs. NSAIDs, according to data presented at ACR Convergence 2022.

News
November 28, 2022
2 min read
Save

‘No clear increased risk’ for CV events with tofacitinib in ORAL Surveillance post-hoc

PHILADELPHIA — There is “no clear increased risk” for major adverse cardiovascular events associated with tofacitinib, according to a post-hoc analysis of the ORAL Surveillance trial presented at ACR Convergence 2022.

News
November 15, 2022
4 min read
Save

EHR-based decision support system helps prevent VTE in hospitalized patients

CHICAGO — In hospitalized medically ill patients, an electronic health record-based decision support system reduced major thromboembolic events compared with usual care, researchers reported.

News
November 11, 2022
2 min read
Save

Thromboembolism linked to shorter survival in metastatic renal cell carcinoma

Thromboembolism incidence appeared high among patients who received immunotherapy-based combinations for metastatic renal cell carcinoma, according to retrospective study results.

News
November 04, 2022
2 min watch
Save

VIDEO: Speaker discusses ‘nuanced’ guidance on VTE management

NASHVILLE, Tenn. — In this Healio exclusive, Samantha Pettigrew, MD, discusses CHEST’s 2021 update to its clinical guidelines on using anticoagulation for venous thromboembolism at the CHEST Annual Meeting.

News
October 25, 2022
2 min read
Save

COVID-19 confers risk for death, CV events, especially in hospitalized patients

Compared with uninfected controls, patients hospitalized for COVID-19 had elevated risk for death and CV events, according to new data from the UK Biobank.

News
October 14, 2022
1 min read
Save

No link between JAK inhibitors, venous thromboembolism in patients with atopic dermatitis

Patients with atopic dermatitis who are on Janus kinase inhibitors did not show an increased risk for venous thromboembolism, according to a study.

News
October 11, 2022
2 min read
Save

Major cardiac events not more common in patients receiving JAK inhibitors vs adalimumab

The risks for major adverse cardiac events and venous thromboembolism in patients with rheumatoid arthritis did not significantly differ between those receiving Janus kinase inhibitors or adalimumab, according to data.

News
September 19, 2022
1 min read
Save

Top in cardiology: Thrombotic risk with contraceptives; multimorbidity in night workers

Combined oral contraceptives were associated with an increased risk for thrombotic events in women with obesity, according to a recent review.

View more